Request a Proposal
Welcome to Rapport, containing tips, truths, news and views, blogs, tweets, articles and films covering a range of topics currently affecting Research Partnership and the pharma market research world
  • Posted by Julie Denny
  • August 24, 2020
  • News

Consumer health specialist joins Research Partnership

Consumer health specialist joins Research Partnership

Jennifer Stewart has joined the US offices in Philadelphia as a Director. Jennifer is a seasoned market research professional with extensive experience in both custom research and marketing consultation. She has 20+ years’ experience on the supplier side with a primary focus on Consumer Healthcare and CPG. Though adept at qualitative research, Jennifer has particular expertise and interest in quantitative research and analysis.

read more »

  • Posted by Pei Li Teh & Wan Ling Neo
  • November 15, 2019
  • Articles

Launching novel oncology therapies in Asia: Identifying and communicating value

Launching novel oncology therapies in Asia: Identifying and communicating value

Novel cancer therapies are offering patients new treatments and better outcomes worldwide. Recent changes in healthcare policies across APAC have reignited interest in the region as a strong market for oncology, such as China's fast tracking approval of therapies for severe and rare diseases and Vietnam's plan to cover health insurance for 80% of the population. Unfortunately, the often eye-watering costs of these new therapies means that, currently, for the many patients who still have to pay for treatment out of pocket, novel therapies are beyong reach. Pharma brands need to demonstate clear value if they want to achieve success. 

read more »

  • Posted by Rachel Howard
  • October 23, 2019
  • Articles

Market access in Brazil: All eyes on Spinraza

Market access in Brazil: All eyes on Spinraza

Director Rachel Howard asks, “What does Brazil’s unprecedented risk-sharing agreement in Spinal Muscular Atrophy (SMA) mean for the future of market access in Brazil?

In April 2019, Brazilian Health Minister Luiz Henrique Mandetta announced a pilot agreement for access to Biogen’s Spinal Muscular Atrophy (SMA) treatment Spinraza (nusinersen) through the Sistema Único de Saúde (SUS). This is the first agreement in Brazil to include a risk-sharing model, in which the government only pays for the drug if there is improvement in the patient's health. In a country where it typically takes years for innovative pharmaceutical products to be reimbursed in the public sector, manufacturers wishing to obtain market access for their products in Brazil will be watching this example closely to see how it plays out.

read more »

  • Posted by Julie Denny
  • August 29, 2018
  • News

Research Partnership continues to expand in the US

Research Partnership continues to expand in the US

We are pleased to announce a number of appointments across our US offices.
Mariana Servin has joined the company’s New York office as Quantitative Director. Mariana has over 18 years’ experience in market research and consulting for pharmaceutical, biotech, medical device and life science clients. She has worked in senior roles for a variety of research and advisory organisations including Quintiles Consulting, Decisions Resources Group and Ipsos Healthcare. Mariana has a wealth of experience in both qualitative and quantitative research, including global work covering Europe, Asia-Pacific and Latin American markets. She joins Research Partnership with a remit for supporting the quantitative side of the business, especially in advanced analytics.

read more »

  • Posted by Helen Parfitt
  • March 28, 2018
  • News

Therapy Watch appoints new Associate Director

Therapy Watch appoints new Associate Director

Research Partnership is delighted to welcome Mark Hollis who has joined the Therapy Watch team in London.

Mark has 8 years’ experience in syndicated healthcare, and previously worked in the Market Prognosis team at IQVIA (IMS Health), where he led field work, analytics, forecasting and report writing for the Middle East and North Africa region. 

read more »